The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
InDuRanS: A randomized phase II trial on induction immunochemotherapy followed by surgery or chemoradiotherapy and consolidation durvalumab in stage III NSCLC.
 
Eleni Gkika
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Novocure
 
Cornelius Waller
No Relationships to Disclose
 
Cas Dejonckheere
No Relationships to Disclose
 
Julian Layer
Stock and Other Ownership Interests - Bayer; BioNTech SE; Siemens Healthineers; TME Pharma
Honoraria - Biotex Inc.; Carl Zeiss Meditec
Consulting or Advisory Role - OncoMagnetX; Siemens Healthineers
Research Funding - Carl Zeiss Meditec (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending
Travel, Accommodations, Expenses - Carl Zeiss Meditec; TME Pharma
 
Jan Meiners
Employment - AstraZeneca
 
Joachim Schmidt
No Relationships to Disclose
 
Peter Brossart
No Relationships to Disclose
 
Ernst Rodermann
No Relationships to Disclose
 
Anne Sofie Schiefer
No Relationships to Disclose
 
Marc Münter
No Relationships to Disclose
 
Nils Nicolay
No Relationships to Disclose
 
Anca-Ligia Grosu
No Relationships to Disclose
 
Andreas Rimner
Consulting or Advisory Role - AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology
 
Severin Schmid
No Relationships to Disclose